Fremanezumab
TV48125-CNS-30084
Approved small_molecule active
Quick answer
Fremanezumab for Migraine is a Approved program (small_molecule) at Teva Pharma GmbH with 9 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Pharma GmbH
- Indication
- Migraine
- Phase
- Approved
- Modality
- small_molecule
- Status
- active